These are pre-specified secondary-endpoint data from phase-3 trials (the HAWK and HARRIER studies) whose successful overall results were presented in Nov 2017 (#msg-136129447).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.